Singapore markets close in 6 hours 45 minutes
Straits Times Index
3,208.21 +28.63 (+0.90%) Nikkei
26,677.84 +0.04 (+0.00%) Hang Seng
19,920.06 -251.21 (-1.25%) FTSE 100
7,522.75 +38.40 (+0.51%) BTC-USD
29,703.56 -66.88 (-0.22%) CMC Crypto 200
659.64 -11.36 (-1.69%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.01B |
| Enterprise value | 465.18M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 115.17 |
| Price/book (mrq) | 1.15 |
| Enterprise value/revenue | 53.11 |
| Enterprise value/EBITDA | -2.19 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -75.67% |
| S&P500 52-week change 3 | -5.29% |
| 52-week high 3 | 19.8400 |
| 52-week low 3 | 3.5700 |
| 50-day moving average 3 | 5.0730 |
| 200-day moving average 3 | 9.0162 |
Share statistics
| Avg vol (3-month) 3 | 1.3M |
| Avg vol (10-day) 3 | 1.01M |
| Shares outstanding 5 | 246.14M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 131.31M |
| % held by insiders 1 | 15.88% |
| % held by institutions 1 | 59.09% |
| Shares short (12 May 2022) 4 | 15.18M |
| Short ratio (12 May 2022) 4 | 24.73 |
| Short % of float (12 May 2022) 4 | 8.90% |
| Short % of shares outstanding (12 May 2022) 4 | 6.17% |
| Shares short (prior month 13 Apr 2022) 4 | 16.63M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,584.93% |
Management effectiveness
| Return on assets (ttm) | -14.52% |
| Return on equity (ttm) | -33.80% |
Income statement
| Revenue (ttm) | 8.76M |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | -77.40% |
| Gross profit (ttm) | 10.65M |
| EBITDA | -210.54M |
| Net income avi to common (ttm) | -263.32M |
| Diluted EPS (ttm) | -1.3670 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 613.91M |
| Total cash per share (mrq) | 2.49 |
| Total debt (mrq) | 68.81M |
| Total debt/equity (mrq) | 7.81 |
| Current ratio (mrq) | 15.24 |
| Book value per share (mrq) | 3.59 |
Cash flow statement
| Operating cash flow (ttm) | -140.5M |
| Levered free cash flow (ttm) | -131.68M |
© 2022 Yahoo. All rights reserved.
